ResApp Provides Update on SMARTCOUGH-C-2 Study Timing

View printer-friendly version Brisbane, Australia, 27 September 2018 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, today provided an update on the...

ResApp Successfully Completes $7.5 Million Capital Raising

View printer-friendly version Brisbane, Australia, 19 September 2018 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce that it...